Sarepta Therapeutics, Inc. misses by $0.06, misses on revenue

|About: Sarepta Therapeutics, Inc. (SRPT)|By:, SA News Editor

Sarepta Therapeutics, Inc. (SRPT): Q4 EPS of -$0.77 misses by $0.06.

Revenue of $2.6M (-64.4% Y/Y) misses by $1.93M.